- Home
- ACHV vs INO Comparison
ACHV vs INO Comparison
Compare ACHV & INO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACHV
- INO
- Stock Information
- Founded
- ACHV N/A
- INO 1979
- Country
- ACHV Canada
- INO United States
- Employees
- ACHV N/A
- INO N/A
- Industry
- ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
- INO Medical/Dental Instruments
- Sector
- ACHV Health Care
- INO Health Care
- Exchange
- ACHV Nasdaq
- INO Nasdaq
- Market Cap
- ACHV 159.0M
- INO 148.3M
- IPO Year
- ACHV N/A
- INO 1998
- Fundamental
- Price
- ACHV $4.98
- INO $5.74
- Analyst Decision
- ACHV Strong Buy
- INO Buy
- Analyst Count
- ACHV 4
- INO 6
- Target Price
- ACHV $15.50
- INO $21.17
- AVG Volume (30 Days)
- ACHV 112.5K
- INO 353.7K
- Earning Date
- ACHV 11-07-2024
- INO 11-07-2024
- Dividend Yield
- ACHV N/A
- INO N/A
- EPS Growth
- ACHV N/A
- INO N/A
- EPS
- ACHV N/A
- INO N/A
- Revenue
- ACHV N/A
- INO $591,858.00
- Revenue This Year
- ACHV N/A
- INO N/A
- Revenue Next Year
- ACHV N/A
- INO N/A
- P/E Ratio
- ACHV N/A
- INO N/A
- Revenue Growth
- ACHV N/A
- INO N/A
- 52 Week Low
- ACHV $3.03
- INO $3.84
- 52 Week High
- ACHV $5.98
- INO $14.75
- Technical
- Relative Strength Index (RSI)
- ACHV 56.44
- INO 44.29
- Support Level
- ACHV $4.85
- INO $5.55
- Resistance Level
- ACHV $5.13
- INO $5.78
- Average True Range (ATR)
- ACHV 0.18
- INO 0.26
- MACD
- ACHV -0.01
- INO 0.09
- Stochastic Oscillator
- ACHV 43.40
- INO 83.02
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.
About INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.